The level of HNRNPC expression in BRCA, Cholangiocarcinoma (CHOL), Colon adenocarcinoma, Esophageal carcinoma (ESCA), Glioblastoma multiforme (GBM), Head and Neck squamous cell carcinoma (HNSC), Kidney chromophobe (KICH), and Liver hepatocellular carcinoma (LIHC) was also assessed (Figure 1B). This evidence concerns the gene HNRNPC and cholangiocarcinoma.